Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which breast reduction surgery works best for men? new study reveals answers

NCT ID NCT07485309

Symptom relief Sponsor: Kafrelsheikh University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study compared two surgical techniques for treating gynecomastia (enlarged male breasts) in 64 men with mild to moderate severity. Participants were randomly assigned to receive either periareolar excision or pull-through surgery, and their satisfaction with chest appearance was measured over 6 months. The goal was to determine which method leads to better outcomes based on the specific type of gynecomastia.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

64 people

The number who actually took part.

Started

Sep 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 50 years

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male patients aged 18 to 50 years * Clinically diagnosed Simon Grade I-IIb gynecomastia * Persistent gynecomastia for more than 18 months * Candidates for surgical correction under general anesthesia * Provided written informed consent to participate in the study Exclusion Criteria: * Simon Grade III gynecomastia requiring skin excision * Gynecomastia secondary to untreated endocrine disorders * Chronic hepatic or renal disease * Suspected or confirmed breast malignancy * Previous gynecomastia surgery * Active infection * Coagulopathy or bleeding disorders * Contraindications to general anesthesia

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gynecomastia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

gynecomastia disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gynecomastia

Contacts and locations

Locations

  • Kafr El-Sheikh University Hospital

    Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33516, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.